One Pill Daily Could Transform Diabetes Treatment
A Nigerian pharmaceutical company has developed an oral tablet for the treatment of type 2 diabetes called Orvoragliberon, marketed under the brand name Foundayo. A clinical study showed that the medication, which is taken once daily and is easier to administer compared to current drugs, results in a significant reduction in blood sugar levels and greater weight loss compared to competing oral treatments. Participants experienced a decrease in their HbA1c levels of up to 2.2 points and a weight loss of up to 9 kilograms after one year. This medication represents an important step in diabetes treatment, although some patients experienced mild gastrointestinal side effects.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)